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Abstract
Background: Non- alcoholic fatty liver disease (NAFLD) affects 20%–30% of adults 
with risk factors like obesity and insulin resistance putatively acting through chronic 
low- grade inflammation. Because periodontitis elicits low- grade inflammation, we hy-
pothesized that it could contribute to NAFLD occurrence.
Objective: To investigate epidemiologic associations between periodontitis and the 
incidence of NAFLD among 2,623 participants of the Study of Health in Pomerania.
Methods: Periodontitis at baseline was defined as the percentage of sites (0%, <30%, 
≥30%)	with	 (i)	clinical	attachment	 level	 (CAL)	≥3	mm;	 (ii)	probing	pocket	depth	 (PD)	
≥4	mm.	Incident	NAFLD	was	defined	as	a	significant	increase	in	liver	echogenicity	on	
ultrasound relative to the kidneys, with the diaphragm indistinct or the echogenic 
walls of the portal veins invisible.
Results: After a median 7.7 years of follow- up, 605 incident NAFLD cases occurred at 
a rate of 32.5 cases per 1,000 person- years. Relative to participants without CAL 
≥3	mm,	NAFLD	incidence	was	elevated	slightly	in	participants	with	<30%	of	sites	af-
fected	 and	 moderately	 in	 participants	 with	 ≥30%	 of	 sites	 affected	 (multivariable-	
adjusted incidence rate ratio = 1.28, 95% CI, 0.84, 1.95 and 1.60, 95% CI, 1.05–2.43), 
respectively. A similar dose–response relationship was not observed for PD.
Conclusion: History of periodontitis may be a risk factor for NAFLD.
1  | INTRODUCTION
Non- alcoholic fatty liver disease (NAFLD), the excessive infiltration of 
triglycerides into hepatocytes in the absence of excessive alcohol con-
sumption (Neuschwander- Tetri & Caldwell, 2003) is the most common 
type of liver disease and the hepatic component of the metabolic syn-
drome (Kotronen & Yki- Järvinen, 2008; Lazo et al., 2013). It comprises 
a spectrum of conditions ranging from steatosis, to non- alcoholic 
steatohepatitis (NASH) with or without fibrosis, to liver cirrhosis and 
hepatocellular carcinoma (Farrell, George, Hall, & McCullough, 2004). 
Depending on race/ethnicity and diagnostic modality, NAFLD is es-
timated to affect 17%–33% of adults in the United States (Angulo, 
2002; Clark, Brancati, & Diehl, 2002; Lazo et al., 2013) and 20%–30% 
worldwide (Bedogni et al., 2005; Bellentani, Bedogni, Miglioli, & 
Tiribelli, 2004; Neuschwander- Tetri & Caldwell, 2003). NAFLD is asso-
ciated with higher healthcare costs (Baumeister et al., 2008) and mor-
tality (Baumeister et al., 2008; Musso, Gambino, Cassader, & Pagano, 
2011), the latter attributed to cardiovascular and other liver disease- 
related complications (Adams et al., 2005; Ong, Pitts, & Younossi, 
2008; Soderberg et al., 2010).
Risk factors include obesity and insulin resistance (Angulo, 2002; 
Neuschwander- Tetri & Caldwell, 2003), the effects of which are thought 
to be mediated via oxidative stress which contributes to NAFLD initia-
tion (Tilg & Moschen, 2010) and progression (Day & James, 1998; Tilg 
& Moschen, 2010). Other conditions eliciting systemic inflammatory 
responses likely contribute to NAFLD occurrence. An example is peri-
odontitis, a chronic oral disease affecting 45% of adults in the United 
States (Eke et al., 2015). It manifests as inflammation of the gums and 
formation of periodontal pockets in response to pathogenic bacteria 
that colonizes the tooth surface. Host response includes production of 
endotoxins, lipopolysaccharides (LPS) and proinflammatory cytokines 
(Gurav & Jadhav, 2011; Yucel- Lindberg & Bage, 2013). In the setting 
of heightened proinflammatory response, the inflammatory process 
causes gradual periodontal destruction and loss of attachment be-
tween periodontal tissues and the tooth. Bacteremia occurs frequently 
in individuals with periodontitis (Schenkein & Loos, 2013). Furthermore, 
sera from individuals affected by periodontitis contain elevated levels 
of LPS which promotes systemic inflammatory response. In addition to 
the systemic inflammatory response elicited, periodontitis also worsens 
glycemic control among diabetics, can impair glucose tolerance among 
non- diabetics and is linked to insulin resistance (Benguigui et al., 2010; 
Chapple & Genco, 2013; Demmer, Jacobs, & Desvarieux, 2008; Lalla 
& Papapanou, 2011; Saito et al., 2004; Stewart, Wager, Friedlander, & 
Zadeh, 2001; Timonen et al., 2011).
Our objectives were to (i) investigate the relationship between 
clinical periodontitis at baseline and (ii) progression of periodontitis on 
the subsequent development of NAFLD.
2  | METHODS
2.1 | Data source and study population
The Study of Health in Pomerania (SHIP) is a population- based co-
hort sampled from the Western Pomeranian region of North- eastern 
Germany. Details of the study design and data collection have 
been described (Hensel et al., 2003; John et al., 2001; Volzke et al., 
2011). Briefly, residents of Western Pomerania aged 20–79 years 
in 1996 were sampled using a two- stage stratified cluster design. 
Communities were selected as part of the first stage, and individuals 
were selected in the second stage after stratifying by age and gender. 
Baseline examinations (SHIP- 0) were conducted between 1997 and 
2001. Of 6,265 eligible persons invited, 4,308 participated in SHIP- 0 
(response rate: 68.8%). Follow- up examinations occurred at approxi-
mate 5- year intervals, with the first follow- up (SHIP- 1) conducted 
between 2002 and 2006 and the second (SHIP- 2) between 2008 
and 2012. A total of 3,300 participated in SHIP- 1 and 2,333 partici-
pated in SHIP- 2. Re- examination participation rates were 76.6% and 
70.7%, respectively. Ethics approval for this study was obtained from 
the Institutional Review Board of the University of North Carolina at 
Chapel Hill.
2.2 | Exposure assessment and characterization
Dental examiners determined periodontitis status at each study visit 
using measures of probing pocket depth (PD) and clinical attachment 
level (CAL). PD, defined as the distance from the free gingival margin 
to the base of the periodontal pocket, is an indicator of periodontitis 
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at the time of examination. CAL, defined as the distance from the 
cemento- enamel junction (a fixed landmark on the tooth) to the base 
of the periodontal pocket, signifies the lifetime history of periodontitis 
up until the time of the examination.
These measurements were made around teeth other than 3rd 
molars in two dental quadrants (a selected quadrant and its ipsilat-
eral quadrant). PD and CAL were recorded at four sites per tooth: the 
mesio- buccal, mid- buccal, disto- buccal and mid- lingual or mid- palatal. 
Measurements were not made when teeth were missing or landmarks 
could not be determined. The maximum number of sites was 56 per 
study participant.




separate exposure category, under the premise that reasons for tooth 
loss probably included some prior experience of periodontitis (Burt & 
Eklund, 2005). In addition, participants’ mean CAL and mean PD at 
baseline were also modelled separately.
Progression of periodontitis was computed as the 5- year change 
in mean CAL between SHIP- 0 and SHIP- 1. This calculation used only 
those periodontal sites that were present at both visits (Beck & Elter, 
2000). The PCP11 periodontal probe was used for periodontal mea-
surements at SHIP- 0, while the PCP2 probe was used at SHIP- 1. Thus, 
mean CAL values were adjusted to minimize biases from digit prefer-
ences as described elsewhere (Holtfreter, Alte, Schwahn, Desvarieux, 
& Kocher, 2012). Because it is measured longitudinally, change in CAL 
is regarded as the cardinal sign of destructive periodontitis (Beck & 
Elter, 2000).
2.3 | Outcome assessment and characterization
Abdominal sonography was performed by trained physicians using a 
7.5- MHz transducer (Vingmed VST Gateway, Santa Clara, CA, USA). 
Levels of serum transaminases i.e. markers of hepatic inflamma-
tion	were	determined	by	analysing	blood	samples	stored	at	−80°C	
using standardized procedures (Hitachi 704; Roche, Mannheim, 
Germany). The presence of fatty liver was assessed using hepatic 
ultrasound and serum transaminase–alanine aminotransferase (ALT) 
at baseline (SHIP- 0); ALT at SHIP- 1; ALT and hepatic ultrasound at 
SHIP- 2. A positive finding on ultrasound was defined as a significant 
increase in liver echogenicity relative to the kidneys, with the dia-
phragm indistinct or the echogenic walls of the portal veins invisible 
(Baumeister et al., 2008; Williams et al., 2011).
Non- alcoholic fatty liver disease case classification was based 
on a combination of ultrasound findings and ALT levels in the ab-
sence of other causes of liver diseases as previously described 
(Clark, Brancati, & Diehl, 2003). NAFLD cases were those with 
a positive finding on ultrasound or ALT above the sex- specific 
upper threshold of normal defined for this study population i.e. 
>0.57 μmol/sl for men and >0.4 μmol/sl for women (equivalent
to >34.2 U/L for men and 24 U/L for women). For SHIP- 1, only
ALT values identified incident NAFLD, thus necessitating a strong
reliance on the exclusion criteria described below in identifying 
“true” cases (Clark et al., 2003). ALT instead of AST was chosen be-
cause ALT is primarily found in the liver; it is a more specific marker 
of hepatocellular injury with levels persisting longer than those of 
AST after an injury.
2.4 | Study exclusions
At baseline, individuals (n = 604) who reported excessive alcohol 
consumption (see Appendix S1) were excluded. Also excluded were 
participants self- reporting the following hepatic steatosis- promoting 
medications: tamoxifen, amiodarone or methotrexate (n = 18) 
(Angulo, 2002; Osman, Osman, & Ahmed, 2007); participants with 
a doctor’s diagnosis of hepatitis B or C in the past year (n = 17), or 
detectable levels of the corresponding antigen (n = 15) or antibody 
(n = 22) in blood samples. Participants with steatosis on ultrasound 
with or without elevated ALT levels (n = 1,265) were excluded as 
prevalent NAFLD cases. Lastly, individuals (n = 14) with missing den-
tal examination data were excluded. Some participants were ineligible 
for multiple reasons.
2.5 | Covariates
Baseline covariates include confounders identified after analysing 
a directed acyclic graph (Greenland, Pearl, & Robins, 1999) and risk 
factors for NAFLD. Age was self- reported and was modelled using 
restricted quadratic splines, thereby allowing for nonlinear relation-
ships between age and NAFLD, and hence better adjustment for po-
tential confounding effects of age than is the case if age was modelled 
using categories or a linear parameter. Gender was reported as male 
or female. Alcohol was adjusted for to minimize any residual effect 
of alcohol and was modelled using restricted quadratic splines. Waist 
circumference was measured in centimetres and modelled using re-
stricted quadratic splines. BMI was categorized into underweight/
normal (<25 kg/m2), overweight (25–30 kg/m2) and obese (>30 kg/
m2). Education was used as a marker of socio- economic position and 
was categorized into <10, 10 and >10 years of formal education. 
Diabetes was based on self- reported physician’s diagnosis or an-
tidiabetic	 treatment	 or	 non-	fasting	 glucose	 levels	 ≥11.1	mmol/L	 or	
glycated	 haemoglobin	 (HbA1c)	 concentration	 ≥6.5%.	 Self-	reported	
smoking was categorized as former, never and current. Physical activ-




Confounding control was accomplished by inverse probability of 
exposure weights (IPEW) (Cole & Hernan, 2008) that included the 
following confounders and NAFLD risk factors as variables: age, 
waist circumference, BMI, alcohol, education, smoking, diabetes and 
 physical activity (see Appendix S1).
2.6.2 | Controlling for censoring due to loss to 
follow- up
The overall loss to follow- up (LTFU) was 40%. Given this magnitude, 
LTFU may be informative to the extent of biasing study findings if 
there are differential losses between exposure groups or with re-
spect to the outcome. To minimize potential biases from LTFU, in-
verse probability of censoring weights (Howe, Cole, Lau, Napravnik, & 
Eron, 2016) were created with the following variables that predicted 
dropping out of study with p < .05: age, gender, smoking, alcohol, PD 
≥4	mm	and	ALT	(see	Appendix	S1).
2.6.3 | Outcome models
Weighted Poisson regression estimated incidence rate (IR), incidence 
rate ratio (IRR) and incidence rate difference (IRD) of NAFLD with 200 
bootstrap resamples (Nevitt & Hancock, 2001) estimating the corre-
sponding standard errors and 95% confidence intervals. In addition, 
confounding and censoring due to LTFU adjusted cumulative risk of 
NAFLD for each exposure groups were estimated and results are pre-
sented graphically.
2.6.4 | Multiple imputation
Multiple imputation was performed for missing data using chained 
equations (White, Royston, & Wood, 2011). The following variables 
were imputed: transaminases (ALT, AST, GGT), alcohol, smoking, BMI 
and waist circumference. Because approximately 40% of transaminase 
values were missing at SHIP- 1 (Table S1), a total of 40 data sets were 
imputed using 500 between imputation iterations. Trace plots (Figure 
S1) assessed how the imputation algorithm performed, while kernel 
density plots (Figure S2) assessed deviation of imputed values from 
observed. Statistical tests were two- sided, and p < .05 was considered 
nominally statistically significant. Analyses (including multiple impu-
tation) were conducted in SAS v.9.4 (SAS Institute, Cary, NC, USA), 
across 40 imputed data sets. The results from each imputed data set 
were summarized using Rubin’s rule (Rubin, 1987) into an overall es-
timate accounting for both within and between imputation variances.
3  | RESULTS
Of the 2,330 participants with baseline PD measurements, 766 
(32.8%)	 had	 no	 sites	with	 PD	≥4	mm	 (periodontally	 healthy),	 1,293	
(49.3%) had up to 30% of sites affected (moderate PD periodontitis) 
and	271	(10.3%)	had	≥30%	sites	affected	 (extensive	PD	periodonti-
tis). Of the 2,233 participants with baseline CAL measurements, 258 
(11.6%) were periodontally healthy, 767 (34.3%) had moderate CAL 
periodontitis and 1,208 (54.1%) had extensive CAL periodontitis. 
There were slightly more female than male participants (59% versus 
41%). The median age at baseline was 46 years (IQR: 33–62), and the 
293 edentulous participants were on average older than participants 
in the other exposure groups (Table 1).
After a median follow- up of 7.7 years (IQR: 2.5–10.6), 588 NAFLD 
cases were identified during 17,973.2 person- years of follow- up 
among the edentulous and participants with baseline CAL measure-
ments and 605 NAFLD cases accrued during 18,595.1 person- years 
of follow- up among the edentulous and participants with baseline PD 
measurements. Approximately 40% of study participants were lost to 
follow- up with edentulous participants having the highest proportion 
of losses at 74% (Table 2).
The unadjusted incidence rate of NAFLD was slightly elevated in 
the two CAL periodontitis groups compared to periodontally healthy 
participants (Table 3), although the IRRs were imprecisely estimated. 
However, upon adjusting for confounders and censoring, there was 
a dose–response relationship in the respective IRRs and IRDs. For in-
stance, the IRR comparing participants with moderate CAL periodon-
titis to periodontally healthy participants was 1.28 (95% CI, 0.84–1.95, 
p = .2) while for extensive CAL periodontitis, the estimate was 1.60 
(95% CI, 1.05–2.43, p = .03). The corresponding IRDs were 5.49 ad-
ditional	 cases	 per	 1,000	 person-	years	 (95%	 CI,	 −2.53–13.5,	 p = .2) 
and 11.9 additional cases per 1,000 person- years (95% CI, 4.09–19.6, 
p = .03), respectively (Table 3). NAFLD rate was also elevated among 
edentulous participants relative to the periodontally healthy, although 
the increase was not significantly different from the null, adjusted 
IRR = 1.37 (95% CI, 0.26–7.15, p = .7). Similar tendencies were seen 
for PD periodontitis, although there was no dose–response relation-
ship in the fully adjusted analysis (Table 3). Qualitatively, similar in-
ferences for CAL and PD were obtained from complete case analysis 
(no data imputation), although the corresponding NAFLD rates were 
smaller (Table S2).
To ensure adequate control for smoking, data analysis was re-
stricted to non- smokers; the results were consistent with those above. 
For instance, the confounding and censoring adjusted IRR comparing 
participants with moderate and extensive CAL periodontitis to peri-
odontally- healthy participants were 1.11 (95% CI, 0.56–2.21, p = .7) 
and 1.72 (95% CI, 0.92–3.21, p = .09), respectively (results not shown). 
Irrespective of the proportion of sites affected, having periodontitis 
increased the cumulative risk of NAFLD (Figure 1a). For PD classifica-
tion, the edentulous group had a greater risk earlier during follow- up; 
however, the risk among participants with PD periodontitis rose 
sharply over the follow- up period (Figure 1b).
The mean CAL at baseline was 2.4 mm (SD: 1.8) per participant 
while the corresponding mean PD was 2.5 mm (SD: 0.7) per partici-
pant. The adjusted IRR of NAFLD for each 3 mm increase in mean CAL 
was 1.11 (95% CI, 0.92–1.34, p = .3) and 1.28 (95% CI, 0.63–2.57, 
p = .5) for each 4 mm increase in mean PD (Table 4).
Among 1,463 eligible participants, progression of periodontitis be-
tween SHIP- 0 and SHIP- 1 was observed for 253 (17.3%) participants 
at	a	threshold	of	≥1	mm	increase	in	mean	CAL	and	for	69	(4.7%)	par-
ticipants	at	a	 threshold	of	≥2	mm	 increase	 in	mean	CAL.	There	was	
no meaningful difference in the IR of NAFLD according to periodon-
titis progression using either threshold. However, there was a signifi-
cant statistical interaction between CAL at baseline and periodontitis 
progression (p	=	.05).	 That	 is,	 among	 participants	 with	 CAL	 ≥3	mm	






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(95% CI, 0.96–4.58, p = .06) (Table 4).
4  | DISCUSSION
4.1 | Summary of current findings
Our results were consistent with a greater incidence rate of NAFLD 
among participants with a history of periodontitis (i.e. CAL periodon-
titis) compared to participants with a healthy periodontium. In con-
trast, a weaker and inconsistent association was observed between 
PD periodontitis and incidence of NAFLD, with the estimate been 
imprecise	and	contrary	to	expectation	among	participants	with	≥30%	
of	sites	with	PD	≥4	mm,	possibly	due	to	the	relatively	small	number	
of participants in this stratum. Progression of periodontitis measured 
over 5 years was also associated with greater incidence of NAFLD, 
although only among participants with a relatively extensive history 
of periodontitis at baseline.
4.2 | Summary of previous findings
Evidence to date of an association between periodontitis and 
NAFLD comes from experimental animal models (Tomofuji et al., 
2007; Yoneda et al., 2012) and a cross- sectional clinic- based study 
(Yoneda et al., 2012). Mice randomized to a high- fat diet and 
Porphyromonas gingivalis (a potent periodontal pathogen) compared 
to those randomized to a high- fat diet alone (Tomofuji et al., 2007; 
Yoneda et al., 2012) had significant increase in body and liver 
weight, and elevated ALT (Yoneda et al., 2012). Substituting P. gin-
givalis with Streptococcus mutans (a dental caries pathogen) had no 
effect on mice body or liver weight. A clinic- based study of biopsy- 
confirmed NAFLD found more NAFLD cases than non- cases to 
have detectable P. gingivalis levels, and a 3- month periodontal 
therapy led to subsequent reductions in elevated transaminases 
(Yoneda et al., 2012). To the extent that persistent infection with 
periodontal pathogens accelerates destruction of periodontal tis-
sues, these findings support biologic plausibility of this study’s 
finding that extensive attachment loss predicts an increased rate 
of NAFLD.
4.3 | Possible biologic mechanisms
The clearer dose–response association between CAL (as compared 
to PD) and NAFLD suggests that a history of periodontitis mat-
ters most in predicting NAFLD in this population. This finding is 
consistent with an underlying hyperinflammatory trait (Shaddox 
et al., 2010) that increases the risk of initiation and progression 
of periodontitis and subsequently to a heightened inflammatory 
response. Unlike the acute inflammatory response to injury, sus-
tained “low- grade” or chronic inflammation (Hotamisligil, 2006) is 
non- beneficial, although it engages similar sets of molecules and 
signalling pathways. This “low- grade” inflammation is central to 
the pathogenesis of obesity- related insulin resistance, an NAFLD 
precursor (Hotamisligil, 2006). Increased serum levels of LPS and 
TNF- α associated with P. gingivalis infection can demonstrably ini-
tiate and worsen insulin resistance (Santos Tunes, Foss- Freitas, & 
Nogueira- Filho, 2010). Therefore, “low- grade” inflammation and 
exacerbation of insulin resistance also likely link periodontitis to 
NAFLD.
Another plausible pathway is created by increased permeability 
in gut epithelia induced by swallowed P. gingivalis, potentially lead-
ing to an alteration in the gut microbial composition (Arimatsu et al., 
2014). Given that the liver is constantly exposed to gut- derived fac-
tors through the portal vein, resident liver cells become activated by 
proinflammatory factors like LPS with subsequent production of cy-
tokines and, reactive oxygen species (ROS), that contribute to liver 
injury (Imajo, Yoneda, Ogawa, Wada, & Nakajima, 2014). Regarding 
NAFLD pathogenesis, the “two hits” (Day & James, 1998) theory 
attributes the “first hit” to steatosis secondary to insulin resistance 
and, the “second hit” to gut- derived bacteria endotoxins which pro-
mote the inflammation that enhances disease progression. A likely 
source of gut- derived bacterial endotoxin is periodontal pathogen- 
derived LPS given that an average 107 copies of periodontal bacteria 
are found in a mL of saliva (Saygun et al., 2011). In experimental an-
imal models, oral administration of P. gingivalis led to changes in the 
gut microbiota leading to metabolic endotoxemia, a precursor for 
metabolic disorders (Arimatsu et al., 2014). While the current study 
lacked microbiologic data, it was noteworthy that progression of 
periodontitis was associated with NAFLD only among participants 
T A B L E  2   Disposition of 2,623 adults free of Non- alcoholic fatty liver disease (NAFLD) with measured periodontal status at baseline, 
followed for a median of 7.7 years in the Study of Health in Pomerania, 1997- 2012















No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Total PY 1,716.3 1,942.0 5,715.3 8,599.6 5,687.1 9,466.2 1,725.5
NAFLD cases 30 (10.4) 57 (21.9) 203 (26.5) 298 (24.6) 182 (23.8) 335 (25.9) 58 (21.5)
Dropout 216 (73.7) 93 (36.1) 226 (29.5) 457 (37.8) 255 (33.3) 433 (33.5) 142 (52.3)
CAL, clinical attachment level; PD, probing pocket depth; PY, person- years.




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































with relatively extensive history of periodontitis. One possible ex-
planation is that progressive loss of periodontal attachment elicits 
systemic responses only when progression is occurring at deep peri-
odontal sites that are more likely anaerobic and capable of eliciting 
systemic inflammation.
4.4 | Clinical and public health implications
This is the first large- scale epidemiologic study to have demonstrated 
an association between history of periodontitis and subsequent inci-
dence rate of NAFLD. Additionally, there was evidence that incidence 
of periodontitis predicted incidence of NAFLD, at least among people 
with a history of extensive CAL. Relative effect estimates were small 
to modest, although given the high prevalence of both periodonti-
tis and NAFLD, the associations, if replicated in future studies, have 
population- wide implications for periodontitis as a modifiable risk fac-
tor for NAFLD.
4.5 | Strengths and limitations
Study limitations include potential misclassification of NAFLD sta-
tus. While ultrasound is used to assess liver diseases in epidemio-
logic settings with reported sensitivity of 85% (95% CI: 80%–89%) 
and specificity of 93% (95% CI: 87%–97%), it is only able to detect 
disease if upwards of 20% of liver cells are affected (Hernaez et al., 
2011). Another limitation is the reliance on ALT for identifying NAFLD 
F I G U R E  1   Panel (a) Confounding 
and censoring adjusted cumulative 
risk curves of Non- alcoholic fatty liver 
disease (NAFLD) occurrence according 
to the proportion of periodontal sites 
with	clinical	attachment	level	of	≥3	mm	
(edentulous, 0%, >0%) at baseline. Panel 
(b) Confounding and censoring adjusted
cumulative risk curves of NAFLD
occurrence according to the proportion
of periodontal sites with probing pocket
depth	of	≥4	mm	(edentulous,	0%,	>0%)	at
baseline
at SHIP- 1 given ALT is not always elevated when NAFLD is present. 
Therefore, if ALT is differentially under- or overestimated according 
to periodontitis status, then estimates are likely biased but the direc-
tion of bias is hard to predict. If non- differential, then estimates are 
likely biased towards the null.
Strengths include the prospective design and the ability to min-
imize temporal ambiguity by ensuring exposure preceded outcome. 
The in- depth characterization of the cohort enabled an extensive as-
sessment of relevant confounding variables, which permitted adjust-
ments not only for confounders but also an assessment of the impact 
of censoring due to LTFU on study findings.
5  | CONCLUSIONS
Non- alcoholic fatty liver disease prevalence is on the rise both in the 
United States and around the world. This investigation is the first to 
implicate history of periodontitis as an independent risk factor con-
tributing to NAFLD incidence in a population- based sample. If these 
findings are replicated in future studies, it would support interven-
tions to control periodontitis would have benefits in reducing NAFLD, 
a condition for which there are no approved pharmacologic interven-
tions, and which is a disease that is difficult to prevent via other life-
style modifications alone.
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